SLU-PP-332 Research Compound For Sale
Buy SLU-PP-332 research compound: 5mg listed purchase quantities. Compare live prices across 1 listed vendor with real cost per mg, recorded COA availability and discount codes.
Buy SLU-PP-332 research compound starting at $67.49/purchase from 1 listed vendor. Compare 5mg purchase quantity options by cost per mg, price per purchase, monthly cost, discount codes and recorded COA metadata (not independent verification).
About SLU-PP-332
Pre-clinical / research-onlyAlso known as: SLU-PP332SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors (ERRα/β/γ), most often sourced for metabolic and "exercise-mimetic" research after 2023 mouse studies. It is not a peptide and not a SARM. No clinical trial has been run and no human safety data exist; it ships as a research powder, typically dissolved for injection in published animal work.[1][2][3]
What to check before you buy SLU-PP-332:
- A third-party COA with mass-spec confirmation that the material is SLU-PP-332 at ≥98% purity by HPLC — not a mislabeled research chemical.
- A COA dated within the last 6–12 months that matches the exact quantity and batch you are buying.
- Accurate fill matching the labeled amount; under-filled units are a common failure mode that throws off any reconstitution or dilution math.
Billon et al. (J Med Chem 2023) characterised SLU-PP-332 as a pan-ERR agonist with metabolic and exercise-mimetic effects in mice.[2] Earlier Burris-lab work characterised the SLU-PP series chemistry and ERR pharmacology in detail.[1] Follow-on academic work has explored SLU-PP-332 in models of heart failure, obesity, and skeletal-muscle adaptation, with the molecule continuing to be used primarily as a pharmacological tool rather than as a clinical candidate.[4][5] There is no registered ClinicalTrials.gov trial of SLU-PP-332 in any indication;[3] consumer use sits entirely outside any clinical framework or human-safety evidence base.
Regulatory: Not FDA-approved. No registered clinical trial. Pre-clinical mouse data only, primarily by parenteral administration. WADA Prohibited List includes metabolic modulators under S4.5. Research-grade material only.
SLU-PP-332: Mechanisms, Half-Life & Research Data
A skimmable deep dive into how SLU-PP-332 works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.
How it works
The ERR family (ERRα, ERRβ, ERRγ) are orphan nuclear receptors with constitutive transcriptional-activator activity at ERR response elements. They are master regulators of mitochondrial-biogenesis (jointly with PGC-1α), fatty-acid-oxidation enzymes, the tricarboxylic-acid cycle, and oxidative-phosphorylation gene programs.[1][5] SLU-PP-332 is a small-molecule pan-agonist that binds all three ERR subtypes and amplifies their transcriptional output, driving upregulation of mitochondrial-biogenesis and energy-metabolism programs in skeletal muscle, brown adipose, and liver. In the flagship 2023 paper, intraperitoneal SLU-PP-332 in obese mice produced an "acute aerobic exercise response" — measurable upregulation of exercise-responsive transcripts — and improved endurance-capacity testing without altering food intake or physical activity levels.[2] Follow-on work has demonstrated cardiac-function benefit in heart-failure mouse models and protection against diet-induced obesity.[1][4] All published in-vivo data are pre-clinical and primarily by parenteral administration in rodents; oral pharmacokinetics in humans are uncharacterised.
Active research areas
- Exercise-mimetic and obesity (pre-clinical)
- Heart failure (pre-clinical)ERRα/γ activation by SLU-PP-332 improved cardiac function in mouse models of heart failure, an indication where the metabolic-substrate-switching pharmacology of ERR activation is mechanistically attractive.[1]
- No human clinical programThere is no registered ClinicalTrials.gov trial of SLU-PP-332 in any indication.[3] All consumer use is occurring outside any clinical-trial framework on the basis of pre-clinical mouse data.
Open questions & leading hypotheses (2)
- Hypothesis: The "exercise mimetic" phenotype from intraperitoneal SLU-PP-332 in mice will translate into a meaningful human endurance, body-composition, or cardiometabolic benefit at any feasible oral or injectable dose.Evidence: The pre-clinical effects are robust and the mechanism (ERR-driven mitochondrial-biogenesis transcription) is biologically rate-limiting in many of the targeted tissues.[1][2][4] Counter-evidence: most exercise-mimetic class compounds (cardarine, SR-9009) have not translated cleanly into human endurance benefit at safe and feasible doses; SLU-PP-332 human pharmacokinetics are uncharacterised; the pan-ERR agonist profile produces broad effects that may have off-target consequences not visible in short pre-clinical studies.
- Hypothesis: Pan-ERR agonism is safe enough at the doses required for an exercise-mimetic effect to consider chronic human use.Evidence: Short-duration pre-clinical mouse studies have not surfaced an obvious safety liability.[2][4] Counter-evidence: the ERR family regulates broad mitochondrial-biogenesis and metabolic-transcription programs across many tissues; pan-agonism (vs. subtype selectivity) increases the chance of off-tissue effects; chronic high-amplitude metabolic-transcription manipulation in humans has not been studied for any ERR agonist; the WADA classification of metabolic modulators reflects a broader regulatory caution about chronic small-molecule manipulation of these pathways in healthy humans.[6]
What community users report
Anecdotal — not controlled-trial evidence
On r/Peptides and biohacking forums, SLU-PP-332 is most often discussed as the "next cardarine" — an emerging exercise-mimetic tool compound that the literature is finally taking seriously.[7] Consumer dosing varies widely because there is essentially no published human pharmacokinetic data, ranging from 10–30mg/day oral to lower-dose subcutaneous protocols. User-reported subjective effects emphasise endurance improvement during cardio sessions, perceived faster recovery, and modest fat-loss support; reported effects vary substantially across users, consistent with the absence of any standardised human dose. **All reports are anecdotal, no published human pharmacokinetic, pharmacodynamic, or safety data exist, the original mouse work used parenteral administration at substantial doses, and the long-term safety of pan-ERR agonism in healthy humans has not been characterised in any way that supports its use outside a controlled-trial setting.** SLU-PP-332 is not FDA-approved, has no registered clinical trial, and metabolic modulators are WADA-prohibited at all times.[6]
Sources & references (7)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Xu W et al. Pharmacological activation of estrogen-related receptor α and γ improves cardiac function in mice with heart failure. Sci Adv 2024;10:eadk9466. · PMID: 38324689 link
- [2]Billon C et al. Synthetic ERRα/β/γ Agonist Induces an ERR-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chem Biol 2023;18:756–771 — flagship SLU-PP-332 exercise-mimetic paper. · PMID: 37000167 link
- [3]ClinicalTrials.gov search "SLU-PP-332", accessed May 2026 — no registered trial. link
- [4]Billon C et al. The estrogen-related receptor agonist SLU-PP-332 protects against diet-induced obesity in mice. eLife 2024;13:e92842. · PMID: 38661463 link
- [5]Burris TP et al. Nuclear receptors and their selective pharmacologic modulators. Pharmacol Rev 2013;65:710–778 — broader ERR pharmacology review context. · PMID: 23457206 link
- [6]World Anti-Doping Agency Prohibited List (2024) — metabolic modulators prohibited at all times under S4.5. link
- [7]Community report — r/Peptides and r/Biohackers SLU-PP-332 discussion threads (subreddits), accessed May 2026. link
What SLU-PP-332 Costs Right Now
WPA currently tracks SLU-PP-332 from 1 distinct vendor. The cheapest in-stock SLU-PP-332 listing is $67.49. LA Peptides holds the lowest sticker price at $67.49. Normalized to milligrams, SLU-PP-332 costs $13.50/mg on this page. The best per-milligram value is the listed 5 mg purchase quantity from LA Peptides.
SLU-PP-332 is stocked in a single size: 5 mg listed quantity; vial count not recorded. Because vials of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.
SLU-PP-332 COA Coverage Across Tracked Vendors
1 of the 1 tracked SLU-PP-332 listings (100%) are marked as having COA availability in WPA's listing data; this marker is not independent verification. A purity value is recorded for 1 listing; purity alone does not establish identity or independent testing. The recorded purity value is 99.60%. 1 listing records more SLU-PP-332 in the vial than the label claims; check the vendor's report and batch before drawing conclusions. The latest COA date recorded in WPA's listing data is 7/26.
To assess a COA, inspect the actual report for the independent lab, test date, and a batch and vial size matching the SLU-PP-332 offer. WPA's listing fields do not establish that a report was independently verified.
SLU-PP-332 Calculator Input Observations
In lifetime SLU-PP-332 calculator inputs, 1mg is the most frequent entered amount (37 of 169 runs). Separately, Daily (7x/wk) is the most frequent overall cadence (13 of 36 lifetime frequency responses, across entered amounts). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. As nominal quantity arithmetic only, 5 mg of listed product divided by 1 mg gives roughly 5.0 portions before preparation losses. This does not establish vial count, stability after preparation, or cycle length.
SLU-PP-332 Discount Codes
1 of the 1 tracked SLU-PP-332 listing carries a WPA researcher discount code. The largest live discount is 10% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.
About SLU-PP-332
SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors (ERRα/β/γ), most often sourced for metabolic and "exercise-mimetic" research after 2023 mouse studies. It is not a peptide and not a SARM. No clinical trial has been run and no human safety data exist; it ships as a research powder, typically dissolved for injection in published animal work.
SLU-PP-332 is tracked under the Weight Loss category on WPA. Its reported half-life is ~2 hours (pre-clinical estimate). Calculator inputs do not establish why a cadence was selected or validate a protocol. Not FDA-approved.
How to Read the SLU-PP-332 Comparison
- Price per milligram — Every SLU-PP-332 listing is normalized to $13.50/mg-style unit pricing, so a small cheap vial cannot hide a worse real cost than a larger one.
- COA metadata and purity — 1 SLU-PP-332 listing is marked for COA availability, and 1 has a recorded purity value. These fields do not independently verify a report.
- Stock status — Live in-stock state for each SLU-PP-332 listing, refreshed on a recurring basis.
Frequently Asked Questions: SLU-PP-332
Is it legal and safe to buy SLU-PP-332 for research?
In the US, SLU-PP-332 is sold strictly as a research chemical — legal to buy for laboratory research but not approved for human use. It is a small-molecule ERR agonist research compound with no approved human form, sold strictly for laboratory research. The real variable isn't legality, it's quality: unverified suppliers can ship underdosed, impure, or mislabeled material. WPA records COA-related listing fields where supplied, but does not independently verify every report. Inspect the actual batch report and its laboratory, identity testing, and date before drawing conclusions. Right now that screen covers 1 SLU-PP-332 listing from 1 vendor.
How do I verify a SLU-PP-332 COA so I'm not getting an underdosed vial?
A Certificate of Analysis (COA) may report tests for a specific SLU-PP-332 batch. Check that the report identifies the compound (actually SLU-PP-332, not an underdosed or substituted vial), names the laboratory, describes the test method and result, and matches the offered batch and date. A recorded purity value or COA-availability flag in WPA's listing data is not independent verification. Open the vendor listing and inspect the actual report before drawing conclusions. For SLU-PP-332 specifically, 1 of 1 tracked listings (100%) are marked as having COA availability in WPA's listing data; that marker is not independent verification. A purity value is separately recorded for 1 listing; purity alone does not establish identity or independent testing. The latest COA date recorded in the listing data is 7/26.
Which SLU-PP-332 vendor should I pick?
There's no single "best" SLU-PP-332 vendor — it depends on what you weigh most. WPA ranks tracked listings using recorded purity and date fields where available, visitor click activity, price, stock status, and discount data; this ranking is not independent verification of a report. As a small-molecule ERR agonist its impurity profile varies widely between sources, so weigh assayed purity and a recent COA heavily. Only LA Peptides stocks SLU-PP-332 among tracked vendors right now, so there is no price competition to arbitrage — weight the COA rather than the price. Review the actual report and confirm its batch details before making a decision.
How much does SLU-PP-332 cost — and how do I know I'm not overpaying?
Judge SLU-PP-332 by true price per milligram, not the sticker price on one vial — a cheap small vial often costs more per mg than a larger one. It most often ships in 5 mg vials, so compare $/mg across those rather than the sticker price on one vial. The best tracked SLU-PP-332 listing works out to $13.50/mg on the listed 5 mg purchase quantity. WPA normalizes tracked listings to $/mg, and the live cost-per-month card estimates your spend at the most common dose. The one catch: the lowest $/mg sometimes means buying a bigger vial than your cycle needs.
How much SLU-PP-332 do I need for one full cycle?
In lifetime SLU-PP-332 calculator inputs, 1mg is the most frequent entered amount (37 of 169 runs). Separately, Daily (7x/wk) is the most frequent overall cadence (13 of 36 lifetime frequency responses, across entered amounts). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. Dividing the listed 5 mg purchase quantity by 1 mg gives roughly 5.0 nominal portions before preparation losses; vial count and stability after preparation are separate questions. A cycle requires an independently chosen amount, cadence and time horizon; calculator observations do not supply those decisions. Compare nominal package quantities and model your own selections in the cost card.
Are discount codes available for SLU-PP-332?
Participating SLU-PP-332 vendors may offer WPA researcher discount codes. Codes can change, exclude sale items or carry order minimums. 1 of the 1 tracked SLU-PP-332 listings carry a code right now, the largest worth 10% off. Each listing shows the recorded code and discounted price where available; confirm the actual package and checkout terms with the vendor.
Where can I compare SLU-PP-332 prices and listing details?
This comparison shows 1 tracked listings for SLU-PP-332 in the selected format. Compare purchase price, established nominal quantities, discount terms and recorded COA availability, purity and date fields. Those fields are not independent verification. Inspect actual batch reports and confirm package composition and checkout price on the vendor's site.